Journal article
Medications for alcohol-use disorder and follow-up after hospitalization for alcohol withdrawal: A multicenter study
Journal of hospital medicine, Vol.19(12), pp.1122-1130
12/2024
DOI: 10.1002/jhm.13458
PMID: 39031461
Abstract
Alcohol withdrawal is a common reason for admission to acute care hospitals. Prescription of medications for alcohol-use disorder (AUD) and close outpatient follow-up are commonly recommended, but few studies report their effects on postdischarge outcomes.BACKGROUNDAlcohol withdrawal is a common reason for admission to acute care hospitals. Prescription of medications for alcohol-use disorder (AUD) and close outpatient follow-up are commonly recommended, but few studies report their effects on postdischarge outcomes.The objective of this study is to evaluate the effects of medications for AUD and follow-up appointments on readmission and abstinence.OBJECTIVESThe objective of this study is to evaluate the effects of medications for AUD and follow-up appointments on readmission and abstinence.This retrospective cohort study evaluated veterans admitted for alcohol withdrawal to medical services at 19 Veteran Health Administration hospitals between October 1, 2018 and September 30, 2019. Factors associated with all-cause 30-day readmission and 6-month abstinence were examined using logistic regression.METHODSThis retrospective cohort study evaluated veterans admitted for alcohol withdrawal to medical services at 19 Veteran Health Administration hospitals between October 1, 2018 and September 30, 2019. Factors associated with all-cause 30-day readmission and 6-month abstinence were examined using logistic regression.Of the 594 patients included in this study, 296 (50.7%) were prescribed medications for AUD at discharge and 459 (78.5%) were discharged with follow-up appointments, including 251 (42.8%) with a substance-use clinic appointment, 191 (32.9%) with a substance-use program appointment, and 73 (12.5%) discharged to a residential program. All-cause 30-day readmission occurred for 150 patients (25.5%) and 103 (17.8%) remained abstinent at 6 months. Medications for AUD and outpatient discharge appointments were not associated with readmission or abstinence. Discharge to residential treatment program was associated with reduced 30-day readmission (adjusted odds ratio [AOR]: 0.39, 95% confidence interval [95% CI]: 0.18-0.82) and improved abstinence (AOR: 2.50, 95% CI: 1.33-4.73).RESULTSOf the 594 patients included in this study, 296 (50.7%) were prescribed medications for AUD at discharge and 459 (78.5%) were discharged with follow-up appointments, including 251 (42.8%) with a substance-use clinic appointment, 191 (32.9%) with a substance-use program appointment, and 73 (12.5%) discharged to a residential program. All-cause 30-day readmission occurred for 150 patients (25.5%) and 103 (17.8%) remained abstinent at 6 months. Medications for AUD and outpatient discharge appointments were not associated with readmission or abstinence. Discharge to residential treatment program was associated with reduced 30-day readmission (adjusted odds ratio [AOR]: 0.39, 95% confidence interval [95% CI]: 0.18-0.82) and improved abstinence (AOR: 2.50, 95% CI: 1.33-4.73).Readmission and return to heavy drinking are common for patients discharged for alcohol withdrawal. Medications for AUD were not associated with improved outcomes. The only intervention at the time of discharge that improved outcomes was discharge to residential treatment program, which was associated with decreased readmission and improved abstinence.CONCLUSIONSReadmission and return to heavy drinking are common for patients discharged for alcohol withdrawal. Medications for AUD were not associated with improved outcomes. The only intervention at the time of discharge that improved outcomes was discharge to residential treatment program, which was associated with decreased readmission and improved abstinence.
Details
- Title: Subtitle
- Medications for alcohol-use disorder and follow-up after hospitalization for alcohol withdrawal: A multicenter study
- Creators
- Nazima Allaudeen - VA Palo Alto Health Care SystemJoyce Akwe - Atlanta Medical CenterCherinne Arundel - Washington DC VA Medical CenterJoel C Boggan - Durham VA Medical CenterPeter Caldwell - Tulane UniversityPaul B Cornia - University of WashingtonJessica Cyr - University of Pittsburgh Medical CenterErik Ehlers - VA Nebraska Western Iowa Health Care SystemJoel Elzweig - White River Junction VA Medical CenterPatrick Godwin - Jesse Brown VA Medical CenterKirsha S Gordon - VA Connecticut Healthcare SystemMichelle Guidry - Tulane UniversityJeydith Gutierrez - Iowa City VA Health Care SystemDaniel Heppe - VA Eastern Colorado Health Care SystemMatthew Hoegh - VA Eastern Colorado Health Care SystemAnand Jagannath - Oregon Health & Science UniversityPeter Kaboli - Iowa City VA Health Care SystemMichael Krug - University of WashingtonJames D Laudate - White River Junction VA Medical CenterChristine Mitchell - VA Nebraska Western Iowa Health Care SystemMicah Pescetto - Kansas City CARE ClinicBenjamin A Rodwin - VA Connecticut Healthcare SystemMatthew Ronan - Harvard UniversityRichard Rose - Lake City VA Medical CenterMeghna N Shah - University of WashingtonAndrea Smeraglio - Oregon Health & Science UniversityMeredith Trubitt - Atlanta Medical CenterMatthew Tuck - Washington DC VA Medical CenterJaclyn VargasPeter Yarbrough - Lake City VA Medical CenterCraig G Gunderson - VA Connecticut Healthcare System
- Resource Type
- Journal article
- Publication Details
- Journal of hospital medicine, Vol.19(12), pp.1122-1130
- DOI
- 10.1002/jhm.13458
- PMID
- 39031461
- NLM abbreviation
- J Hosp Med
- ISSN
- 1553-5606
- eISSN
- 1553-5606
- Language
- English
- Electronic publication date
- 07/19/2024
- Date published
- 12/2024
- Academic Unit
- Epidemiology; General Internal Medicine; Internal Medicine
- Record Identifier
- 9984658252202771
Metrics
7 Record Views